Your browser doesn't support javascript.
loading
Establishing a core outcome measure for life participation in patients receiving peritoneal dialysis: A Standardised Outcomes in Nephrology-Peritoneal Dialysis consensus workshop report.
Cheetham, Melissa S; Wilkie, Martin; Loud, Fiona; Manera, Karine E; Ju, Angela; Figueiredo, Ana; Farragher, Janine; Hurst, Helen; Jassal, Sarbjit V; Mehrotra, Rajnish; Morton, Rachael L; Schwartz, Daniel; Shen, Jenny I; Walker, Rachael; Cho, Yeoungjee; Johnson, David W; Craig, Jonathan C; Anumudu, Samaya; Baumgart, Amanda; Gonzalez, Andrea Matus; Scholes-Robertson, Nicole; Viecelli, Andrea K; Tong, Allison.
Afiliação
  • Cheetham MS; Department of Nephrology, Sunshine Coast University Hospital, Birtinya, Australia.
  • Wilkie M; Sunshine Coast Health Institute, Birtinya, Australia.
  • Loud F; Faculty of Medicine, University of Queensland, Brisbane, Australia.
  • Manera KE; Department of Nephrology, Sheffield Teaching Hospitals NHS Foundation Trust, UK.
  • Ju A; Kidney Care UK, London, UK.
  • Figueiredo A; Sydney School of Public Health, The University of Sydney, New South Wales, Australia.
  • Farragher J; Centre for Kidney Research, Children's Hospital at Westmead, New South Wales, Australia.
  • Hurst H; Sydney School of Public Health, The University of Sydney, New South Wales, Australia.
  • Jassal SV; Centre for Kidney Research, Children's Hospital at Westmead, New South Wales, Australia.
  • Mehrotra R; School of Health Sciences and Life, Nursing School, Pontificia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
  • Morton RL; Department of Occupational Science and Occupational Therapy, University of Toronto, Ontario, Canada.
  • Schwartz D; Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, University of Manchester, UK.
  • Shen JI; Division of Nephrology, Department of Medicine, University Health Network, University of Toronto, Ontario, Canada.
  • Walker R; Division of Nephrology/Department of Medicine, University of Washington, Seattle, WA, USA.
  • Cho Y; NHMRC Clinical Trials Centre, University of Sydney, New South Wales, Australia.
  • Johnson DW; Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Craig JC; Division of Nephrology and Hypertension, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Anumudu S; School of Nursing, Eastern Institute of Technology, Hawke's Bay, New Zealand.
  • Baumgart A; Faculty of Medicine, University of Queensland, Brisbane, Australia.
  • Gonzalez AM; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Scholes-Robertson N; Australasian Kidney Trials Network, Centre for Health Services Research, University of Queensland, Brisbane, Queensland, Australia.
  • Viecelli AK; Translational Research Institute, Brisbane, Australia.
  • Tong A; Faculty of Medicine, University of Queensland, Brisbane, Australia.
Perit Dial Int ; 42(6): 562-570, 2022 11.
Article em En | MEDLINE | ID: mdl-35538693
BACKGROUND: Life participation is an outcome of critical importance to patients receiving peritoneal dialysis (PD). However, there is no widely accepted or validated tool for measuring life participation in patients receiving PD. METHODS: Online consensus workshop to identify the essential characteristics of life participation as a core outcome, with the goal of establishing a patient-reported outcome measure for use in all trials in patients receiving PD. Thematic analysis of transcripts was performed. RESULTS: Fifty-six participants, including 17 patients and caregivers, from 15 countries convened via online videoconference. Four themes were identified: reconfiguring expectations of daily living (accepting day-to-day fluctuation as the norm, shifting thresholds of acceptability, preserving gains in flexibility and freedom), ensuring broad applicability and interpretability (establishing cross-cultural relevance, incorporating valued activities, distinguishing unmodifiable barriers to life participation), capturing transitions between modalities and how they affect life participation (responsive to trajectory towards stable, reflecting changes with dialysis transitions) and maximising feasibility of implementation (reducing completion burden, administrable with ease and flexibility). CONCLUSIONS: There is a need for a validated, generalisable outcome measure for life participation in patients receiving PD. Feasibility, including length of time to complete and flexible mode of delivery, are important to allow implementation in all trials that include patients receiving PD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article